MedPath

To compare and evaluate the effect of mild versus moderate haemodilution during cardiopulmonary bypass on the neurological complications in patients undergoing heart valve replacement surgery.

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/09/057179
Lead Sponsor
Department of Anaesthesiology, SMS Medical College and Attached Hospitals.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Informed written consent.

Patients with valvular surgery.

Aged between 30 and 60 years.

Exclusion Criteria

Previous neurological disease.

Congestive heart failure.

Diabetes, Hypertension.

Acute Myocardial Infarction.

Atrial fibrillation or obstructive cardiomyopathy.

Renal or Hepatic Impairment.

HCT < 21%

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eurological Complications <br/ ><br>Cerebral oximetry values.Timepoint: On post op day 2,4, 6. <br/ ><br>During Surgery 15 & 30 minutes after initiation of Cardiopulmonary bypass and 5 minutes before weaning of cardiopulmonary bypass.
Secondary Outcome Measures
NameTimeMethod
Hemodynamic Variables PR, MAP, CVP, SpO2.Timepoint: Baseline, 15 minutes after intubation, before cardiopulmonary bypass, 30 minutes after cardiopulmonary bypass, at ICU admission, 6hours, 12hours & 24 hours after ICU admission.
© Copyright 2025. All Rights Reserved by MedPath